Network Pharmacology and Anticancer Mechanism Study of Dendrobium Nobile Dendrobine in the Treatment of Colorectal Cancer

Overview

Journal Discov Oncol

Publisher Springer

Specialty Oncology

Date 2024 Dec 18

PMID 39692955

Authors

Pei Luo

Can Huang

Jun Guo

Xin Yao

Chao Pan

Aijin Bao

Fei Li

Ying-Ying Li

Affiliations

Soon will be listed here.

Abstract

Objective: This study aims to explore the potential targets and anticancer mechanisms of dendrobine from Dendrobium nobile in the treatment of colorectal cancer through network pharmacology, and to experimentally validate its specific effects.

Methods: Initially, potential targets of dendrobine were identified using the ITCM Traditional Chinese Medicine database, while colorectal cancer-related genes were obtained from the NCBI Gene database, with the intersection of these datasets taken for further analysis. Functional enrichment analysis was conducted using the Metascape database, and a protein-protein interaction (PPI) network was constructed. Additionally, cell culture, cell proliferation assays, and wound healing assays were performed. The Wnt/β-catenin and NF-κB/COX-2/PGE signaling pathways were analyzed using PCR and Western blot experiments.

Results: The PPI network constructed from 152 intersecting genes revealed that these genes play crucial roles in processes such as cell proliferation, apoptosis, and signal transduction. Cell-based assays demonstrated that dendrobine significantly inhibits the proliferation and migration of colorectal cancer cells. Furthermore, PCR and Western blot results indicated that dendrobine suppresses colorectal cancer cell proliferation and migration by modulating the Wnt/β-catenin and NF-κB/COX-2/PGE signaling pathways.

Conclusion: Dendrobine exhibits significant anticancer potential against colorectal cancer by regulating the Wnt/β-catenin and NF-κB/COX-2/PGE signaling pathways, providing a theoretical foundation and experimental evidence for its therapeutic application in colorectal cancer.

References

Clemons N, Phillips W . Trapping Colorectal Cancer Into a Dead-end. Gastroenterology. 2021; 161(1):33-35. DOI: 10.1053/j.gastro.2021.03.046. View

Zhao L, Zhang H, Li N, Chen J, Xu H, Wang Y . Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol. 2023; 309:116306. DOI: 10.1016/j.jep.2023.116306. View

Krieg A, Kolbe E, Kaspari M, Krieg S, Loosen S, Roderburg C . Trends and outcomes in colorectal cancer surgery: a multicenter cross-sectional study of minimally invasive versus open techniques in Germany. Surg Endosc. 2024; 38(11):6338-6346. PMC: 11525431. DOI: 10.1007/s00464-024-11210-1. View

Kim Y, Han A, Kim J, Jung C . Dendrobine Inhibits γ-Irradiation-Induced Cancer Cell Migration, Invasion and Metastasis in Non-Small Cell Lung Cancer Cells. Biomedicines. 2021; 9(8). PMC: 8392411. DOI: 10.3390/biomedicines9080954. View

Liu K, Zhang X, Zhang J, Tsang L, Jiang X, Chan H . Defective CFTR- β-catenin interaction promotes NF-κB nuclear translocation and intestinal inflammation in cystic fibrosis. Oncotarget. 2016; 7(39):64030-64042. PMC: 5325423. DOI: 10.18632/oncotarget.11747. View

Ahmad R, Singh J, Wunnava A, Al-Obeed O, Abdulla M, Srivastava S . Emerging trends in colorectal cancer: Dysregulated signaling pathways (Review). Int J Mol Med. 2021; 47(3). PMC: 7834960. DOI: 10.3892/ijmm.2021.4847. View

Sun P, Quan J, Wang S, Zhuang M, Liu Z, Guan X . lncRNA-PACER upregulates and PGE2 through the NF-κB pathway to promote the proliferation and invasion of colorectal-cancer cells. Gastroenterol Rep (Oxf). 2021; 9(3):257-268. PMC: 8309685. DOI: 10.1093/gastro/goaa060. View

Tian S, Chen M . The mechanisms and drug therapies of colorectal cancer and epigenetics: bibliometrics and visualized analysis. Front Pharmacol. 2024; 15:1466156. PMC: 11391208. DOI: 10.3389/fphar.2024.1466156. View

Weng W, Goel A . Curcumin and colorectal cancer: An update and current perspective on this natural medicine. Semin Cancer Biol. 2020; 80:73-86. PMC: 7438305. DOI: 10.1016/j.semcancer.2020.02.011. View

10.

Wu H, Xue D, Deng M, Guo R, Li H . Progress, challenges, and future perspectives of robot-assisted natural orifice specimen extraction surgery for colorectal cancer: a review. BMC Surg. 2024; 24(1):255. PMC: 11389085. DOI: 10.1186/s12893-024-02538-5. View

11.

Klimeck L, Heisser T, Hoffmeister M, Brenner H . Colorectal cancer: A health and economic problem. Best Pract Res Clin Gastroenterol. 2023; 66:101839. DOI: 10.1016/j.bpg.2023.101839. View

12.

Disoma C, Zhou Y, Li S, Peng J, Xia Z . Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?. Biochimie. 2022; 195:39-53. DOI: 10.1016/j.biochi.2022.01.009. View

13.

Fan C, Sun X, Wang X, Yu H . Therapeutic potential of the chemical composition of Lindl. Front Pharmacol. 2023; 14:1163830. PMC: 10366689. DOI: 10.3389/fphar.2023.1163830. View

14.

Liu C, Rokavec M, Huang Z, Hermeking H . Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis. Cell Death Differ. 2023; 30(7):1771-1785. PMC: 10307888. DOI: 10.1038/s41418-023-01178-1. View

15.

Jiashuo W, Fangqing Z, Zhuangzhuang L, Weiyi J, Yue S . Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review. J Tradit Chin Med. 2022; 42(3):479-486. PMC: 9924699. DOI: 10.19852/j.cnki.jtcm.20220408.003. View

16.

Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M . Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022; 21(1):144. PMC: 9281132. DOI: 10.1186/s12943-022-01616-7. View

17.

Baidoun F, Elshiwy K, Elkeraie Y, Merjaneh Z, Khoudari G, Sarmini M . Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes. Curr Drug Targets. 2020; 22(9):998-1009. DOI: 10.2174/1389450121999201117115717. View

18.

Bian J, Dannappel M, Wan C, Firestein R . Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer. Cells. 2020; 9(9). PMC: 7564852. DOI: 10.3390/cells9092125. View

19.

Dang T, Guan X, Cui L, Ruan Y, Chen Z, Zou H . Epigenetics and immunotherapy in colorectal cancer: progress and promise. Clin Epigenetics. 2024; 16(1):123. PMC: 11385519. DOI: 10.1186/s13148-024-01740-9. View

20.

Feng Y, Lu J, Jiang J, Wang M, Guo K, Lin S . Berberine: Potential preventive and therapeutic strategies for human colorectal cancer. Cell Biochem Funct. 2024; 42(4):e4033. DOI: 10.1002/cbf.4033. View